Cargando…

DNA Methylation as a Biomarker for Cardiovascular Disease Risk

BACKGROUND: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myungjin, Long, Tiffany I., Arakawa, Kazuko, Wang, Renwei, Yu, Mimi C., Laird, Peter W.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837739/
https://www.ncbi.nlm.nih.gov/pubmed/20300621
http://dx.doi.org/10.1371/journal.pone.0009692
_version_ 1782178847646547968
author Kim, Myungjin
Long, Tiffany I.
Arakawa, Kazuko
Wang, Renwei
Yu, Mimi C.
Laird, Peter W.
author_facet Kim, Myungjin
Long, Tiffany I.
Arakawa, Kazuko
Wang, Renwei
Yu, Mimi C.
Laird, Peter W.
author_sort Kim, Myungjin
collection PubMed
description BACKGROUND: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FINDINGS: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45–74 years recruited during 1993–1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P = 0·01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P = 0·03) but not in women (P = 0·53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5·8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P = 0·007). CONCLUSIONS/SIGNIFICANCE: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.
format Text
id pubmed-2837739
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28377392010-03-18 DNA Methylation as a Biomarker for Cardiovascular Disease Risk Kim, Myungjin Long, Tiffany I. Arakawa, Kazuko Wang, Renwei Yu, Mimi C. Laird, Peter W. PLoS One Research Article BACKGROUND: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FINDINGS: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45–74 years recruited during 1993–1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P = 0·01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P = 0·03) but not in women (P = 0·53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5·8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P = 0·007). CONCLUSIONS/SIGNIFICANCE: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese. Public Library of Science 2010-03-15 /pmc/articles/PMC2837739/ /pubmed/20300621 http://dx.doi.org/10.1371/journal.pone.0009692 Text en Kim et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kim, Myungjin
Long, Tiffany I.
Arakawa, Kazuko
Wang, Renwei
Yu, Mimi C.
Laird, Peter W.
DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title_full DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title_fullStr DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title_full_unstemmed DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title_short DNA Methylation as a Biomarker for Cardiovascular Disease Risk
title_sort dna methylation as a biomarker for cardiovascular disease risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837739/
https://www.ncbi.nlm.nih.gov/pubmed/20300621
http://dx.doi.org/10.1371/journal.pone.0009692
work_keys_str_mv AT kimmyungjin dnamethylationasabiomarkerforcardiovasculardiseaserisk
AT longtiffanyi dnamethylationasabiomarkerforcardiovasculardiseaserisk
AT arakawakazuko dnamethylationasabiomarkerforcardiovasculardiseaserisk
AT wangrenwei dnamethylationasabiomarkerforcardiovasculardiseaserisk
AT yumimic dnamethylationasabiomarkerforcardiovasculardiseaserisk
AT lairdpeterw dnamethylationasabiomarkerforcardiovasculardiseaserisk